Nanosonics | NAN - Sales Revenues

Stock Price
3.85
Daily Change
0.17 4.62%
Monthly
7.84%
Yearly
-16.85%
Q2 Forecast
3.62

Nanosonics reported AUD102.23M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Alcidion AUD 25.47M 2.32M Dec/2025
Ansell USD 1.03B 192.2M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Fisher & Paykel Healthcare NZD 1.09B 9.2M Sep/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Pro Medicus AUD 128.94M 50.69M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.45B 470M Dec/2025